2016

Strickland, M.R., Gill, C.M., Nayyar, N., D'Andrea, M.R., Thiede, C., Juratli, T.A., Schackert, G., Borger, D.R., Santagata, S., Frosch, M.P., Cahill, D.P., Brastianos, P.K. & Barker, F.G., 2nd (2016) Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas. J Neurosurg, 1-7.

Rasche, L., Rollig, C., Stuhler, G., Danhof, S., Mielke, S., Grigoleit, G.U., Dissen, L., Schemmel, L., Middeke, J.M., Rucker, V., Schreder, M., Schetelig, J., Bornhauser, M., Einsele, H., Thiede, C. & Knop, S. (2016) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features. Biol Blood Marrow Transplant, 22, 1988-1996.

Proschmann, R., Baldow, C., Rothe, T., Suttorp, M., Thiede, C., Tauer, J.T., Muller, M.C., Hochhaus, A., Roeder, I. & Glauche, I. (2016) Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy. Haematologica.

Platzbecker, U., Avvisati, G., Cicconi, L., Thiede, C., Paoloni, F., Vignetti, M., Ferrara, F., Divona, M., Albano, F., Efficace, F., Fazi, P., Sborgia, M., Di Bona, E., Breccia, M., Borlenghi, E., Cairoli, R., Rambaldi, A., Melillo, L., La Nasa, G., Fiedler, W., Brossart, P., Hertenstein, B., Salih, H.R., Wattad, M., Lubbert, M., Brandts, C.H., Hanel, M., Rollig, C., Schmitz, N., Link, H., Frairia, C., Pogliani, E.M., Fozza, C., D'Arco, A.M., Di Renzo, N., Cortelezzi, A., Fabbiano, F., Dohner, K., Ganser, A., Dohner, H., Amadori, S., Mandelli, F., Ehninger, G., Schlenk, R.F. & Lo-Coco, F. (2016) Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial. J Clin Oncol.

Oelschlaegel, U., Alexander Rohnert, M., Mohr, B., Sockel, K., Herold, S., Ehninger, G., Bornhauser, M., Thiede, C. & Platzbecker, U. (2016) Clonal architecture of del(5q) myelodysplastic syndromes: aberrant CD5 or CD7 expression within the myeloid progenitor compartment defines a subset with high clonal burden. Leukemia, 30, 517-520.

Muller-Tidow, C., Tschanter, P., Rollig, C., Thiede, C., Koschmieder, A., Stelljes, M., Koschmieder, S., Dugas, M., Gerss, J., Butterfass-Bahloul, T., Wagner, R., Eveslage, M., Thiem, U., Krause, S.W., Kaiser, U., Kunzmann, V., Steffen, B., Noppeney, R., Herr, W., Baldus, C.D., Schmitz, N., Gotze, K., Reichle, A., Kaufmann, M., Neubauer, A., Schafer-Eckart, K., Hanel, M., Peceny, R., Frickhofen, N., Kiehl, M., Giagounidis, A., Gorner, M., Repp, R., Link, H., Kiani, A., Naumann, R., Brummendorf, T.H., Serve, H., Ehninger, G., Berdel, W.E., Krug, U. & Study Alliance Leukemia, G. (2016) Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia. Leukemia, 30, 555-561.

Middeke, J.M., Herold, S., Rucker-Braun, E., Berdel, W.E., Stelljes, M., Kaufmann, M., Schafer-Eckart, K., Baldus, C.D., Stuhlmann, R., Ho, A.D., Einsele, H., Rosler, W., Serve, H., Hanel, M., Sohlbach, K., Klesse, C., Mohr, B., Heidenreich, F., Stolzel, F., Rollig, C., Platzbecker, U., Ehninger, G., Bornhauser, M., Thiede, C., Schetelig, J. & Study Alliance, L. (2016) TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation. Br J Haematol, 172, 914-922.

Middeke, J.M., Herbst, R., Parmentier, S., Bug, G., Hanel, M., Stuhler, G., Schafer-Eckart, K., Rosler, W., Klein, S., Bethge, W., Bitz, U., Buttner, B., Knoth, H., Alakel, N., Schaich, M., Morgner, A., Kramer, M., Sockel, K., von Bonin, M., Stolzel, F., Platzbecker, U., Rollig, C., Thiede, C., Ehninger, G., Bornhauser, M. & Schetelig, J. (2016) Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial. Leukemia, 30, 261-267.

Kayser, S., Benner, A., Thiede, C., Martens, U., Huber, J., Stadtherr, P., Janssen, J.W., Rollig, C., Uppenkamp, M.J., Bochtler, T., Hegenbart, U., Ehninger, G., Ho, A.D., Dreger, P. & Kramer, A. (2016) Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. Blood Cancer J, 6, e449.

Hones, J.M., Botezatu, L., Helness, A., Vadnais, C., Vassen, L., Robert, F., Hergenhan, S.M., Thivakaran, A., Schutte, J., Al-Matary, Y.S., Lams, R.F., Fraszscak, J., Makishima, H., Radivoyevitch, T., Przychodzen, B., da Conceicao Castro, S.V., Gorgens, A., Giebel, B., Klein-Hitpass, L., Lennartz, K., Heuser, M., Thiede, C., Ehninger, G., Duhrsen, U., Maciejewski, J.P., Moroy, T. & Khandanpour, C. (2016) GFI1 as a novel prognostic and therapeutic factor for AML/MDS. Leukemia, 30, 1237-1245.

Ho, A.D., Schetelig, J., Bochtler, T., Schaich, M., Schafer-Eckart, K., Hanel, M., Rosler, W., Einsele, H., Kaufmann, M., Serve, H., Berdel, W.E., Stelljes, M., Mayer, J., Reichle, A., Baldus, C.D., Schmitz, N., Kramer, M., Rollig, C., Bornhauser, M., Thiede, C. & Ehninger, G. (2016) Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD. Biol Blood Marrow Transplant, 22, 462-469.

Hartmann, L., Dutta, S., Opatz, S., Vosberg, S., Reiter, K., Leubolt, G., Metzeler, K.H., Herold, T., Bamopoulos, S.A., Braundl, K., Zellmeier, E., Ksienzyk, B., Konstandin, N.P., Schneider, S., Hopfner, K.P., Graf, A., Krebs, S., Blum, H., Middeke, J.M., Stolzel, F., Thiede, C., Wolf, S., Bohlander, S.K., Preiss, C., Chen-Wichmann, L., Wichmann, C., Sauerland, M.C., Buchner, T., Berdel, W.E., Wormann, B.J., Braess, J., Hiddemann, W., Spiekermann, K. & Greif, P.A. (2016) ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation. Nat Commun, 7, 11733.

Creutzig, U., Zimmermann, M., Reinhardt, D., Rasche, M., von Neuhoff, C., Alpermann, T., Dworzak, M., Perglerova, K., Zemanova, Z., Tchinda, J., Bradtke, J., Thiede, C. & Haferlach, C. (2016) Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups. Cancer, 122, 3821-3830.

Bochtler, T., Frohling, S., Weichert, W., Endris, V., Thiede, C., Hutter, B., Hundemer, M., Ho, A.D. & Kramer, A. (2016) Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia. Cold Spring Harb Mol Case Stud, 2, a001123.

Balss, J., Thiede, C., Bochtler, T., Okun, J.G., Saadati, M., Benner, A., Pusch, S., Ehninger, G., Schaich, M., Ho, A.D., von Deimling, A., Kramer, A. & Heilig, C.E. (2016) Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemia. Leukemia, 30, 782-788.